Smart devices in diabetes: improving clinical outcomes and enhancing lifestyle



Janus Henderson Client Portfolio Manager and type 1 diabetic Jen Nichols describes how new smart medical technology has helped her to train for and compete in ultra-marathons. Global Life Sciences Portfolio Manager Ethan Lovell discusses the opportunities that breakthrough medical devices present to investors.
Key takeaways:
  • Continuous Glucose Monitors (CGM) and insulin pumps that communicate with smartphones and wearable devices have the ability to transform the lives of people with diabetes.
  • By constantly monitoring blood sugar, diabetics can better manage their short- and long-term clinical needs.
  • Makers of the medical devices that offer clear and substantial advantages to patients may provide investment opportunities for active stock pickers.


Past performance is not a guide to future performance. The value of an investment and the income from it can fall as well as rise and you may not get back the amount originally invested.

The information in this article does not qualify as an investment recommendation.

For promotional purposes.

Anything non-factual in nature is an opinion of the author(s), and opinions are meant as an illustration of broader themes, are not an indication of trading intent, and are subject to change at any time due to changes in market or economic conditions. It is not intended to indicate or imply that any illustration/example mentioned is now or was ever held in any portfolio. No forecasts can be guaranteed and there is no guarantee that the information supplied is complete or timely, nor are there any warranties with regard to the results obtained from its us.

Important information

Please read the following important information regarding funds related to this article.

Janus Henderson Global Life Sciences Fund

Specific risks

Risk rating


Important message